 |
Ricin (blocked) conjugated murine MCA (anti-my9) |
|---|---|
| Trade Name | |
| Orphan Indication | For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1990-02-01 00:00:00 |
| Sponsor | ImmunoGen, Inc.;830 Winter Street;Waltham, Massachusetts, 02451 |
